Evidence map›Paper›PMID 9528771›Full record

ArticleMolecular and cellular biology1998

Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

M H Kaplan, C Daniel, U Schindler, M J Grusby

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 126 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Transcriptional regulation by STAT6.Immunologic research · 2011
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. JAK-STAT signaling in asthma.The Journal of clinical investigation · 2002
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M H KaplanDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
C Daniel
U Schindler
M J Grusby
Harvard University · US

Funding

REGULATION OF THE DIFFERENTIATION AND FUNCTION OF TH2 CER01AI040171 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI GRUSBY, MICHAEL J · 1997 to 2006
$1.9M
ALTERING INTERLEUKIN 4 FUNCTION IN VIVOR21AI040171 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GRUSBY, MICHAEL J · 1996 to 1996
–
NIAID NIH HHS AI40171NIAID NIH HHS R01 AI040171
6 · The paper itself

Abstract

The proliferation of lymphocytes in response to cytokine stimulation is essential for a variety of immune responses. Recent studies with signal transducer and activator of transcription 6 (Stat6)-deficient mice have demonstrated that this protein is required for the normal proliferation of lymphocytes in response to interleukin-4 (IL-4). In this report, we show that the impaired IL-4-induced proliferative response of Stat6-deficient lymphocytes is not due to an inability to activate alternate signaling pathways, such as those involving insulin receptor substrates, or to a failure to upregulate IL-4 receptor levels. Cell cycle analysis showed that the percentage of Stat6-deficient lymphocytes that transit from the G1 to the S phase of the cell cycle following IL-4 stimulation is lower than that of control lymphocytes. Although the regulation of many genes involved in the control of cytokine-induced proliferation is normal in Stat6-deficient lymphocytes, protein levels of the cdk inhibitor p27Kip1 were found to be markedly dysregulated. p27Kip1 is expressed at significantly higher levels in Stat6-deficient lymphocytes than in control cells following IL-4 stimulation. The higher level of p27Kip1 expression seen in IL-4-stimulated Stat6-deficient lymphocytes correlates with decreased cdk2-associated kinase activity and is the result of the increased accumulation of protein rather than altered mRNA expression. Similarly, higher levels of p27Kip1 protein expression are also seen following IL-12 stimulation of Stat4-deficient lymphocytes than are seen following stimulation of control cells. These data suggest that Stat proteins may control the cytokine-induced proliferative response of activated T cells by regulating the expression of cell cycle inhibitors so that cyclin-cdk complexes may function to promote transition from the G1 to the S phase of the cell cycle.

Indexed as

CDC2-CDC28 KinasesCell Cycle ProteinsTumor Suppressor ProteinsAnimalsCell DivisionCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesG1 PhaseInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsLymphocytesMiceMicrotubule-Associated ProteinsPhosphoproteinsCDC2-CDC28 KinasesCdk2 protein, mouseCdkn1b protein, mouseCell Cycle ProteinsCyclin-Dependent Kinase 2Cyclin-Dependent Kinase Inhibitor p27Cyclin-Dependent KinasesInsulin Receptor Substrate ProteinsInterleukin-4Intracellular Signaling Peptides and ProteinsIrs1 protein, mouseIrs2 protein, mouseMicrotubule-Associated ProteinsPhosphoproteinsProtein Serine-Threonine KinasesReceptors, Interleukin-4Stat6 protein, mouseSTAT6 Transcription FactorTrans-ActivatorsTumor Suppressor Proteins

Identifiers

PMID9528771
PMCPMC121429
OpenAlexW2103912229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.